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SUMMARY
Determinants of anticipated acceptance of an oral cholera vaccine (OCV) were studied in urban
and rural communities of Western Kenya. An explanatory model interview administered to 379
community residents assessed anticipated vaccine acceptance at various prices from no cost to
full-cost recovery, socio-cultural features of cholera and social characteristics. Nearly all (99%)
residents indicated willingness to accept a no-cost OCV, 95% at a price of US$ 0.8, 73% at US$
4.2 and 59% at US$ 8.4. Logistic regression models analysed socio-cultural determinants of
anticipated OCV acceptance. Prominence of non-speciﬁc symptoms for cholera was negatively
associated with acceptance. A cholera-speciﬁc symptom (thirst), self-help referring to prayer,
income and education were positively associated. In the high-cost model, education was no longer
signiﬁcant and reliance on herbal treatment was a signiﬁcant determinant of vaccine non-
acceptance. Findings suggest high motivation for OCVs, if aﬀordable. Socio-cultural
determinants are better predictors of anticipated acceptance than socio-demographic factors
alone.
Key words : Cholera, Kenya, oral cholera vaccine, social and cultural determinants, vaccine
acceptance.
INTRODUCTION
Among infectious diseases, diarrhoeal diseases rank as
the third leading cause of mortality and morbidity in
low- and middle-income countries [1]. It is estimated
that diarrhoeal diseases account for 1.78 million
deaths per year and 58.7 million disability-adjusted
life years. Cholera, a rapidly dehydrating diarrhoeal
disease, is estimated to cause the death of 100 000–
130 000 persons and account for 3–5 million cases
per year [2]. Kenya suﬀers from a high burden of
cholera, having reported 11 425 cases and 264 deaths
in 2009 [3].
Cholera transmission is closely associated with en-
vironmental conditions, spread by faecal contami-
nation of water and food [4]. Access to safe water and
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adequate sanitation are fundamentals of cholera pre-
vention. In many countries, however, implementing
relevant measures has proved diﬃcult and slow [2, 5].
Furthermore, improvements may not reach the most
vulnerable populations, such as those living in slums
and remote rural areas, in the near future [5]. Vaccines
may therefore have a critical role as a provisional
public health tool in cholera control in these com-
munities. In 2005, the World Health Organization
(WHO) ﬁrst suggested oral cholera vaccines (OCVs)
be used in cholera-endemic areas as a supplementary
control strategy [6] and they strengthened that
recommendation in 2010 [4].
Two OCVs are currently pre-qualiﬁed by the WHO
for international use. Both Dukoral1 (Crucell, The
Netherlands), containing recombinant cholera toxin
B subunit and killed whole-cell V. cholerae O1, and
ShancholTM (Shantha Biotechnics Ltd, India), con-
taining killed V. cholerae O1 and O139, have been
shown to be eﬃcacious in endemic settings [7, 8].
Although safety, eﬃcacy and an eﬃcient health system
to distribute the vaccine are critical, understanding
cultural preferences and the willingness of communi-
ties to accept the vaccine are also essential. Assessing
socio-cultural features of the illness and willingness to
accept a vaccine indicate perceived need, demand and
cultural barriers that may reduce coverage in a vac-
cine campaign. Notwithstanding recognized value
of such research [9, 10], studies have been largely
conﬁned to high-income countries [11, 12]. Cholera
vaccine acceptance studies focus mainly on socio-
demographics and willingness to pay [13–15], while
studies that have considered socio-cultural aspects of
cholera have concentrated on Asia [16, 17]. Research
is lacking on cultural dimensions and social determi-
nants of cholera vaccine acceptance in Kenya.
This study was conducted in Nyanza province of
Western Kenya due to the disproportionately high
number of cholera cases reported there compared to
the rest of Kenya [18]. Two large cholera outbreaks
occurred there in 1997–1998 and 2008 that accounted
for 43–47% and 72%, respectively, of all cholera
cases in Kenya [19, 20]. Urban and rural sites were
chosen because they diﬀer signiﬁcantly in terms of
environmental conditions, population density, resi-
dents’ income and occupation; the implication being
that the ﬁndings from one setting may not be at-
tributable to the other. Cultural epidemiological
methods [21] were employed to understand com-
munity experience, meaning and behaviour with a
cholera-like illness. The objectives of this paper are to
(a) assess community willingness to accept an OCV
in urban and rural populations in Western Kenya,
(b) analyse socio-cultural determinants of anticipated
OCV acceptance and (c) clarify the role of socio-
cultural features of illness in explaining anticipated
OCV acceptance by comparing models that consider




This study was conducted at both urban and rural
sites in Nyanza province, Western Kenya, where
cholera is considered endemic. The urban site at
Nyalenda A, Winam division, Kisumu district is a
heavily populated informal settlement and the rural
site is comprised of villages at Kakum Kombewa sub-
location, Boro division, Siaya district.
The urban site covers an area of 2.8 km2, has 23 731
residents and a population density of 8475 persons/
km2 [22]. The majority of residents do not have ac-
cess to piped water and largely rely on shallow wells
that are subject to a high level of contamination due
to the predominance of pit latrines [22, 23]. There are
no government health facilities in Nyalenda A and
private health services involve higher costs to be
borne.
The rural site is comprised of nine villages at
Kakum Kombewa with a population density of
around 270 individuals/km2 [24]. Main sources of
water in this region are untreated streams and bore-
holes. The majority (73%) of the population have
access to latrines ; however, over 24% of these are in a
poor state and hence not used [24]. Lack of public
transport makes access to Siaya district hospital,
which is located about 15 km away, diﬃcult.
Study design and sampling
This cross-sectional study required a minimum sam-
ple size of 328 to allow for cross-site comparisons with
95% signiﬁcance and 80% power [25]. Men and
women from the general population between the ages
of 18 and mid-60s were included.
At the urban site, only an estimate of the popu-
lation size was obtainable, hence, systematic prob-
ability sampling was done. The area was divided into
seven roughly equal segments and every ﬁfth house-
hold was approached to get a total of 28 households
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per segment. At the rural site, detailed household lists
were accessible through community health workers. A
speciﬁc number of households per village, pro-
portional to the total number of households in that
village, which had been identiﬁed in advance through
random selection, were approached. At both sites,
one willing adult of the household was interviewed;
selection was made to maintain a roughly equal bal-
ance between men and women. When more than one
eligible adult was available, we asked them to decide
whom we should interview. If a household had no
suitable, willing candidate, the neighbouring house-
hold was approached.
Instrument and data collection
This study used a semi-structured explanatory model
interview based on the framework of the Explanatory
Model Interview Catalogue (EMIC) for cultural epi-
demiology [26]. It was developed for the study of
cholera to assess locally valid features of illness-
related experience, meaning and behaviour from the
perspective of community residents [27]. The illness
was introduced to participants using a clinical vignette
that described a person with physical symptoms of
cholera. Respondents were asked what they would
call such an illness and the term for the illness pro-
vided by the respondent was used when asking further
questions. In addition to questions on socio-cultural
features of illness (i.e. physical symptoms, social im-
pact, perceived causes, help-seeking behaviour), the
interview also included questions on respondents’
socio-demographic characteristics and their ideas on
general vaccination. Quantitative and qualitative data
were both collected.
Respondents were also asked if they would be
willing to take a vaccine that is swallowed to prevent
cholera. Details of eﬃcacy and duration of protection
were not discussed. OCV acceptance questions were
posed at four diﬀerent prices : ‘high’, based on esti-
mated full production cost recovery for manufacture
of two doses of Dukoral (KES 650/US$ 8.4)# ; ‘me-
dium’, which is half the high price (KES 325/US$
4.2) ; ‘ low’, close to the US$ 1 price that is considered
a realistic vaccine price for low- and middle-income
countries (KES 65/US$ 0.8) [16] and ‘free ’, fully
subsidized as in the case of many immunization cam-
paigns.
Interviews were conducted between March and
May 2010, in Kiswahili, Dholuo and English.
Interviewers received extensive training in sampling
procedures, interviewing and obtaining informed
consent. The interviewers were science or social sci-
ence graduates from Maseno University and in-
troduced themselves accordingly. Interviews were
voice-recorded with permission.
Data management and analysis
EMIC interview data were double-entered using Epi
Info software version 3.5.1 (Centers for Disease
Control and Prevention, USA), programmed with
logic and range checks. For analysis of socio-cultural
features of illness, prominence of categories was cal-
culated based on whether a response was reported
spontaneously (assigned value of 2) or after probing
(assigned value of 1). When a category was identiﬁed
as most important among all others, it was assigned
an additional value of 3. A mean prominence was
then calculated for each category. Through this
method of prominence calculation, categories were
evaluated based on relative importance ascribed to
them by local cultural ideas.
Logistic regression analyses were done to empiri-
cally identify socio-cultural determinants (i.e. socio-
cultural features of illness and socio-demographic
characteristics) associated with anticipated OCV
acceptance at various prices. Dichotomized antici-
pated OCV acceptance variables, reﬂecting vaccine
acceptance or non-acceptance, were used as outcome
variables. Separate regression analyses were per-
formed for anticipated OCV acceptance at the me-
dium price and at the high price, but not for the low
price or no-cost models as acceptance rates over 95%
did not allow for it.
In crude analysis, associations between OCV
acceptance and explanatory variables that were
reported by 5–95% of respondents were analysed.
Variables with P<0.2 were considered for multi-
variate analysis. ‘Focal ’ models of socio-cultural
features of illness for speciﬁc groups of variables
(i.e. related to physical symptoms, social impact,
perceived causes, help-seeking), adjusted for socio-
demographic variables, were run. Focal models
for socio-demographic factors alone were also con-
sidered. Interaction of site with each of the variables
was tested and site-interaction terms with P<0.1
were included. To estimate the combined inﬂuence
of all categories identiﬁed in the focal models on
# Exchange rate : Kenya shilling (KES) 1=US$ 0.01287 as of
1 March 2010 (www.oanda.com).
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anticipated OCV acceptance, a ‘comprehensive’
model was calculated using variables with P<0.2
and site-interaction terms with P<0.1 from focal
models. Corrected Akaike’s Information Criterion
(AICc) values were computed to compare relative
goodness of ﬁt in various focal and comprehensive
regression models. D(AICc) which represents the
diﬀerence in AICc between each model and the
model with the lowest AICc, was used to make this
comparison. Models with lower D(AICc) values
are considered better in explaining OCV acceptance
than those with higher values. Quantitative analysis
was done with SAS version 9.2 (SAS Institute Inc.,
USA).
Narrative accounts were translated into English
and entered in word processor software. Additional
detail from key questions of the interview was ad-
ded by transcribing relevant voice records. Typed
data were then imported into MAXQDA version 10
(VERBI Software, Germany) for qualitative data
management and analysis. Text segments were the-
matically coded based on the interview structure.
Variables were imported into MAXQDA to enable
the selection of narrative records of interest based
on results from the quantitative analysis. This ap-
proach enabled integrated analysis of quantitative
and qualitative data.
Ethical considerations
The study protocol received ethical approval from the
Kenya Medical Research Institute and the WHO
Research Ethics Review Committee. Interviews were
conducted after obtaining written informed consent.
No ﬁnancial or other incentives were provided to re-
spondents. Data collected in this study was main-




Of 379 respondents interviewed, 50% were from the
urban site and 51% were female (Table 1). All re-
spondents at the rural site and 96.8% at the urban site
identiﬁed Christianity as their religion. The median
personal monthly income was KES 2500 (US$ 32) at
the urban site and KES 1000 (US$ 13) at the rural
site (P=0.01). Signiﬁcantly more respondents at the
urban site reported a dependable source of income.
Self-employment (e.g. petty trading and skilled
labour) was the most frequently mentioned primary
occupation at the urban site ; and agriculture at
the rural site. Urban respondents were better edu-
cated: more in the urban sample had a secondary
education or higher ; more in the rural sample had
no education. The rural site had signiﬁcantly more
individuals living within a household than at the
urban site.
Past experience with vaccination and general ideas
on vaccines
Two-thirds (66.8%) of all respondents reported
having personally received a vaccination in the
past. Fewer respondents reported prior vaccination
experience at the rural (51.3%) than at the urban
(82.1%, P<0.001) site.
All but four respondents (98.9%) stated that in
their experience, vaccines were helpful. The idea that
vaccines were beneﬁcial in preventing disease was
reported pervasively. More knowledgeable respon-
dents provided accounts with a scientiﬁc basis, such
as, ‘Vaccines are helpful ; they boost the immune sys-
tem and prevent future infections ’ (urban woman,
22 years). There also seemed to be a high level of
conﬁdence in the protective eﬀect of vaccines, as seen
in this narrative, ‘ I rarely get sick because I was vac-
cinated’ (urban man, 30 years).
When asked whether some vaccines were also likely
to cause problems, 27.7% of the respondents agreed;
pain at the injection site, infection/abscess, fever
and disability were frequently cited problems. Of re-
spondents who believed that vaccines were not likely
to cause problems, there was a signiﬁcant diﬀerence in
terms of site (P=0.036) and gender (P=0.007), with
more women and more urban respondents espousing
this view.
Anticipated OCV acceptance
Almost all respondents (98.7%) reported an interest
in accepting an OCV if it were to be made available
free of charge (Fig. 1). At the low price, 95.3% re-
spondents were willing to accept the vaccine. At the
medium and high prices, 72.8% and 58.8% re-
spondents, respectively, were interested in the vaccine.
More urban than rural respondents were willing
to accept an OCV at the medium (P=0.008) and high
(P=0.002) prices. Anticipated OCV acceptance rates
between men and women were similar.
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Narrative accounts demonstrate an active demand
for cholera vaccines. A sense of urgency in obtaining
cholera vaccines was communicated as follows:
We have a water problem because there is a lot of pollution
in the water and water points are scarce. We are also far
from the hospital in Siaya. So I ask, when will this vaccine
come? Or will you just disappear after the research? We
really need the vaccine (rural man, 32 years).
A highly mentioned reason for willingness to pur-
chase an OCV was that it would be more cost-eﬀective
than spending money on cholera treatment in the
future.
Vaccine cost was a critical point of consideration
for many respondents. While requesting a free vac-
cine, a 35-year-old rural woman explained:
If a vaccine is introduced, let it be free of charge so that it
can help everyone. If it is brought with a price, others will
die if they cannot aﬀord it.
However, demand for a vaccine was high enough for
respondents to oﬀer suggestions that could enable
vaccine purchase, even if it could not be availed for
free.
If you bring the vaccine, tell us in advance so that we have
enough time to collect money to pay for it. If you come
without notice, we may not have the money ready (rural
woman, 26 years).
The idea that health was more important than money
was widespread and many stated: ‘You cannot com-
pare your life to money. ’
Determinants of anticipated OCV acceptance at the
medium price and high price
Focal regression models considered speciﬁc groups
of explanatory variables in explaining anticipated
OCV acceptance at the medium and high prices
(Tables 2 and 3). As per their D(AICc) values, at
the medium price, ‘ somatic symptoms’ and ‘self-
treatment at home’ models explained acceptance bet-
ter than the focal model with only socio-demographic
Table 1. Socio-demographic characteristics of study respondents
Overall (n=379) Urban (n=190) Rural (n=189) P valued
Gender (%)
Female 51.2 52.1 50.3
Age (years)
Mean (S.D.)a 32.8 (13.1) 28.9 (10.1) 36.8 (14.5) ***
Median (range)b 29 (18–69) 25 (18–63) 33 (18–69) ***
Household size (persons)
Mean (S.D.)a 4.5 (2.3) 4.3 (2.1) 4.7 (2.6) *
Main occupation (%)c
Agriculture 25.3 1.6 49.2 ***
Self-employed 26.6 36.8 16.4 ***
Formal employment 12.4 16.8 7.9 *
Housewife 9.0 14.7 3.2 ***
Casual labourer 9.2 12.1 6.3
Student 5.5 6.3 4.8
Not active/retired 9.5 10.0 9.0
Highest education level attended (%)c
No education 3.7 0.5 6.9 ***
Primary school 50.1 44.7 55.6 *
Secondary school 37.7 46.8 28.6 ***
Vocational school 1.8 0.0 3.7 **
College and above 6.6 7.9 5.3
Household income (%)c




c Fisher’s exact test. Only categories with overall reported percentages>1.5% are displayed.
d P value obtained from a comparison between the urban and rural site ; * Pf0.05 ; ** Pf0.01 ; *** Pf0.001.
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characteristics. At the high price, all socio-cultural
focal models were better than the exclusively socio-
demographic model. Comprehensive models, which
combined signiﬁcant variables from all focal models,
explained OCV acceptance best.
Most variables that were signiﬁcant in the focal
models remained so in the comprehensive models.
Socio-cultural determinants identiﬁed in the compre-
hensive models that were associated with anticipated
OCV acceptance at the medium price and the high
price are shown in Tables 4 and 5, respectively.
Although diﬀerent explanatory variables were ident-
iﬁed in the analyses at the two price levels, they refer
to coherent themes explaining anticipated OCV ac-
ceptance: speciﬁcity of symptoms for cholera, level of
education, restricted preference for treatment and
ﬁnancial viability.
Identiﬁcation of physical symptoms that were
unrelated to cholera such as bloody stool, and non-
speciﬁc for cholera such as loss of appetite and
confusion, were negatively associated with OCV ac-
ceptance. A cholera-speciﬁc symptom of being ‘very
thirsty’ was positively associated.
Having attended secondary school was positively
associated with OCV acceptance at the medium price.
However, this did not remain signiﬁcant at the high
price.
With an increase in price of the vaccine from
medium to high, the reporting of herbal treatment
as a home remedy became signiﬁcantly negatively
associated with acceptance. In contrast, the reporting
of prayer as a form of self-treatment at home was
positively associated with OCV acceptance at both
prices. An analysis of qualitative accounts revealed
that prayer and medical interventions are considered
complementary forms of treatment, carried out in
parallel. Prayer and medicine are believed to have
diﬀerent, but non-conﬂicting roles, in treatment.
‘Prayer must be conducted to have God’s inter-
vention while pharmacy drugs help in controlling the
situation’ (urban woman, 22 years). However, medi-
cal help was often implicitly assigned a greater pri-
ority while prayer was recommended in addition.
Even a respondent who stated, ‘Prayer helps because
God is above everything, even above drugs’, further
mentioned that she would ﬁrst give the patient
water and drugs to combat diarrhoea, and thereafter
pray.
Household income and household size signiﬁ-





















































Fig. 1. Anticipated oral cholera vaccine (OCV) acceptance at diﬀerent prices among urban and rural residents of Western
Kenya. OCV price mentioned in Kenya shillings (KES) to respondents : low (KES 65/US$ 0.8), medium (KES 325/US$ 4.2),
and high (KES 650/US$ 8.4) (exchange rate : KES 1=US$ 0.01287). Y axis denotes percentage of respondents who provided
a favourable response when questioned on whether they were likely to buy the vaccine at the stated price. Fisher’s exact test
was used for comparison of percentages between the two sites. ** Pf0.01.
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Table 2. Multivariate analysis (focal models) of socio-cultural determinants of anticipated oral cholera vaccine
acceptance at the medium price (US$ 4.2) and assessment of models
Focal modelsa Coeﬃcient (95% CI)b P valuec Intd D(AICc)e
Patterns of distress : somatic symptoms 3.25
Bloody stool (urban site) 0.35 (x0.30 to 1.00) 0.288
Bloody stool (rural site) x0.43 (x0.75 tox0.11) 0.008 *
Very thirsty 0.61 (0.02 to 1.21) 0.044
Loss of appetite x0.73 (x1.16 tox0.31) 0.001
Palpitations x0.08 (x0.41 to 0.26) 0.652
Confusion x0.52 (x0.92 tox0.12) 0.012
Patterns of distress : social impact 22.6
Fear of infecting others 0.17 (x0.10 to 0.45) 0.217
Perceived causes 24.43
Eating soil 0.09 (x0.41 to 0.60) 0.723
Malaria x0.29 (x0.87 to 0.28) 0.318
Violation of taboo/tradition x0.17 (x0.59 to 0.26) 0.437
Other causes (urban site)f 0.13 (x0.28 to 0.54) 0.527
Other causes (rural site)f x0.37 (x0.64 tox0.09) 0.010 *
Cannot say x0.15 (x0.34 to 0.05) 0.137
Self-treatment at home 17.27
Drinking more water or liquids 0.11 (x0.06 to 0.28) 0.212
Herbal treatment x0.23 (x0.44 tox0.01) 0.040
Prayers 0.43 (0.07 to 0.79) 0.021
Drink with alcohol 0.53 (x0.24 to 1.31) 0.178
Socio-demographicsg 22.08
Primary school vs. no education 0.58 (x0.57 to 1.73) 0.325
Secondary school vs. no education 1.02 (x0.17 to 2.22) 0.093
Regular and dependable household income
(urban site)
1.54 (0.79 to 2.30) <0.001
Regular and dependable household income
(rural site)
0.12 (x0.58 to 0.82) 0.739 **
Household size x0.07 (x0.17 to 0.03) 0.189
Occupation : housewife, student, retiredh x0.26 (x0.98 to 0.46) 0.474
Occupation : self-employed, formally employed,
casual labourh
0.23 (x0.42 to 0.88) 0.479
Gender (male vs. female) 0.25 (x0.26 to 0.76) 0.330
Site (rural vs. urban) 0.36 (x0.35 to 1.07) 0.316
a Each of the four focal models (somatic symptoms, social impact, perceived causes, self-treatment at home) were adjusted
for socio-demographic characteristics.
b Logistic regression coeﬃcient with 95% conﬁdence interval.
c Bold values indicate Pf0.05.
d Interaction with site : refers to rural compared to urban site, with urban site as the baseline. Site-speciﬁc eﬀects on variables
considered only if P<0.1 for site-interaction term. * Pf0.05, ** Pf0.01.
e Diﬀerence in corrected Akaike’s Information Criterion [D(AICc)] between each model and the model with the lowest AICc.
Comprehensive model (Table 4) had the lowest AICc and was assigned a value of zero. Models with lowerD(AICc) values are
considered better ﬁtted than those with higher values. Bold values indicate models that are better than the model containing
only socio-demographic characteristics.
f ‘Other causes’ refers to responses that could not be coded within designated categories of the interview. The variety of
responses coded under ‘other causes’ included contact with infected persons, unprotected sexual intercourse, cold weather,
mosquitoes, breathing in contaminated air and eating cold food.
g Variables with which each focal model was adjusted.
h Compared with the occupation of agriculture.
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positively associated while an increasing household
size was negatively associated.
Site-speciﬁc interactions were not observed for any
variables at the high price and were present for just
one variable at the medium price.
DISCUSSION
Findings from this study indicate high levels of ac-
ceptance for an OCV among urban and rural residents
inWesternKenya. Quantitative and narrative analysis
showed that respondents perceive a general beneﬁt
from immunization. The extensive interest and de-
mand for OCVs indicates a likelihood of good cover-
age during mass vaccination initiatives. The study
also showed that 91.3% of the respondents con-
sidered the illness as very serious and 96.3% believed
that it had life-threatening consequences. The pros-
pect of an eﬀective vaccine campaign is further sup-
ported by this data given the widely acknowledged
Table 3. Multivariate analysis (focal models) of socio-cultural determinants of anticipated oral cholera vaccine
acceptance at the high price (US$ 8.4) and assessment of models
Focal modelsa Coeﬃcient (95% CI)b P valuec Intd D(AICc)e
Patterns of distress : somatic symptoms 11.9
Abdominal pain/discomfort 0.30 (x0.01 to 0.60) 0.055
Loss of appetite x0.63 (x1.03 tox0.23) 0.002
Weakness x0.12 (x0.35 to 0.12) 0.319
Palpitations 0.07 (x0.25 to 0.39) 0.669
Confusion (urban site) 0.21 (x0.41 to 0.83) 0.502
Confusion (rural site) x1.02 (x1.66 tox0.39) 0.002 **
Perceived causes 32.22
Other causes (urban site)f 0.08 (x0.30 to 0.46) 0.691
Other causes (rural site)f x0.35 (x0.63 tox0.08) 0.013 #
Self-treatment at home 24.08
Drinking more water or liquids 0.07 (x0.10 to 0.23) 0.421
Herbal treatment x0.27 (x0.48 tox0.06) 0.010
Oral rehydration solution x0.12 (x0.26 to 0.02) 0.094
Prayers 0.43 (0.11 to 0.76) 0.009
Socio-demographicsg 33.54
Primary school vs. no education 0.58 (x0.61 to 1.77) 0.339
Secondary school vs. no education 0.78 (x0.43 to 1.99) 0.209
Regular and dependable household income 0.72 (0.25 to 1.18) 0.002
Household size x0.07 (x0.17 to 0.02) 0.122
Occupation: housewife, student, retiredh x0.12 (x0.80 to 0.55) 0.716
Occupation: self-employed, formally employed,
casual labourh
0.02 (x0.58 to 0.62) 0.950
Gender (male vs. female) 0.33 (x0.12 to 0.78) 0.153
Site (rural vs. urban) x0.34 (x0.87 to 0.20) 0.216
a Each of the three focal models (somatic symptoms, perceived causes, self-treatment at home) were adjusted for socio-
demographic characteristics.
b Logistic regression coeﬃcient with 95% conﬁdence interval.
c Bold values indicate Pf0.05.
d Interaction with site : refers to rural compared to urban site, with urban site as the baseline. Site-speciﬁc eﬀects on variables
considered only if P<0.1 for site-interaction term. # P<0.1, ** Pf0.01.
e Diﬀerence in corrected Akaike’s Information Criterion [D(AICc)] between each model and the model with the lowest AICc.
Comprehensive model (Table 5) had the lowest AICc and was assigned a value of zero. Models with lower D(AICc) values are
considered better ﬁtted than those with higher values. Bold values indicate models that are better than the model containing
only socio-demographic characteristics.
f ‘Other causes ’ refers to responses that could not be coded within designated categories of the interview. The variety of
responses coded under ‘other causes ’ included contact with infected persons, unprotected sexual intercourse, cold weather,
mosquitoes, breathing in contaminated air and eating cold food.
g Variables with which each focal model was adjusted.
h Compared with the occupation of agriculture.
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Table 4. Multivariate analysis (comprehensive model) of socio-cultural
determinants of anticipated oral cholera vaccine acceptance at the medium
price (US$ 4.2)
Explanatory variables Coeﬃcient (95% CI)a P valueb
Patterns of distress : somatic symptoms
Bloody stool x0.29 (x0.56 tox0.01) 0.042
Very thirsty 0.57 (x0.01 to 1.15) 0.054
Loss of appetite x0.77 (x1.19 tox0.34) <0.001
Confusion x0.54 (x0.94 tox0.13) 0.009
Perceived causes
Other causesc x0.16 (x0.38 to 0.07) 0.166
Self-treatment at home
Herbal treatment x0.16 (x0.37 to 0.06) 0.153
Prayers 0.46 (0.09 to 0.82) 0.015
Socio-demographics
Primary school vs. no education 0.70 (x0.60 to 2.00) 0.291
Secondary school vs. no education 1.37 (0.03 to 2.71) 0.045
Regular and dependable
household income
0.93 (0.40 to 1.46) 0.001
Household size x0.10 (x0.21 to 0.01) 0.063
a Logistic regression coeﬃcient with 95% conﬁdence interval.
b Bold values indicate Pf0.05.
c ‘Other causes’ refers to responses that could not be coded within designated
categories of the interview. The variety of responses coded under ‘other causes’
were contact with infected persons, unprotected sexual intercourse, cold weather,
mosquitoes, breathing in contaminated air and eating cold food.
Table 5. Multivariate analysis (comprehensive model) of socio-cultural
determinants of anticipated oral cholera vaccine acceptance at the high price
(US$ 8.4)
Explanatory variables Coeﬃcient (95% CI)a P valueb Intc
Patterns of distress : somatic symptoms
Abdominal pain/discomfort 0.27 (x0.04 to 0.58) 0.085
Loss of appetite x0.64 (x1.04 tox0.23) 0.002
Confusion (urban site) 0.19 (x0.46 to 0.83) 0.568
Confusion (rural site) x1.08 (x1.73 tox0.42) 0.001 **
Self-treatment at home
Herbal treatment x0.27 (x0.48 tox0.06) 0.012
Oral rehydration solution x0.11 (x0.25 to 0.03) 0.113
Prayers 0.42 (0.09 to 0.74) 0.013
Socio-demographics
Gender (male vs. female) 0.39 (x0.09 to 0.87) 0.107
Site (rural vs. urban) 0.73 (x0.17 to 1.62) 0.111
Primary school vs. no education 0.95 (x0.41 to 2.31) 0.172
Secondary school vs. no education 1.28 (x0.12 to 2.67) 0.074
Regular and dependable
household income
0.81 (0.31 to 1.30) 0.001
Household size x0.11 (x0.21 tox0.01) 0.031
a Logistic regression coeﬃcient with 95% conﬁdence interval.
b Bold values indicate Pf0.05.
c Interaction with site : refers to rural compared to urban site, with urban site
as the baseline. Site-speciﬁc eﬀects on variables considered only if P<0.1 for site-
interaction term. **Pf0.01.
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observation that perceived severity of a disease is
closely associated with likelihood of vaccine uptake
[10, 28].
This study demonstrated that socio-cultural de-
terminants explained anticipated vaccine acceptance
better than socio-demographic factors alone. Identiﬁc-
ation of such socio-cultural determinants of OCV
acceptance provides data relevant to ensure better
coverage in an actual campaign. Past cholera control
campaigns that have faced severe community resist-
ance [29], and free treatment initiatives for other
diseases that were rejected [30], further underscores
the importance of paying attention to local socio-
cultural environments prior to interventions. Com-
munity studies are necessary to plan and prepare for
vaccine campaigns [31]. This study provides an ap-
proach to integrate qualitative and quantitative em-
pirical data, explain local cultural concepts of illness
and guide disease control.
Several determinants of anticipated OCV accept-
ance were notable. Thirst, a cholera-speciﬁc symp-
tom, was associated positively with acceptance.
Non-speciﬁc physical symptoms for cholera were as-
sociated with a lower priority for the vaccine. Bloody
stool, a characteristic symptom of other diarrhoeal
illnesses, such as shigellosis, amoebic dysentery, cam-
pylobacteriosis, etc., was also negatively associated
with OCV acceptance. The ability to discern cholera
symptoms from symptoms of other diarrhoeal ill-
nesses argues for a high level of awareness in the
community. These ﬁndings also indicate that eﬀorts
to promote community awareness during control
interventions need to highlight cholera-speciﬁc
symptoms. Furthermore, given the deﬁnitive ideas of
cholera possessed by the community, non-speciﬁc
reference to diarrhoeal illness may lead to unreason-
able expectations that the OCV will prevent all
diarrhoea, leading to disappointment and possible
discrediting of a useful vaccine.
Education was a predictor of vaccine acceptance.
Interestingly, health education was reported as the
most useful method of preventing cholera by the
majority of respondents, and was frequently re-
quested. A similar ﬁnding was reported from a study
in Pakistan where education and knowledge about
vaccines were associated with vaccine uptake [32].
These ﬁndings highlight the value of education and
promoting health awareness in cholera control. How-
ever, at the high price, secondary school education
was no longer signiﬁcantly associated with OCV ac-
ceptance, indicating that education too has the ability
to inﬂuence acceptance only to a certain extent.
Above a certain price, economic factors may play a
more prominent role in inﬂuencing OCV acceptance.
At the high price, self-help with herbal treatment
was a signiﬁcant negative determinant of acceptance.
It appears that higher cost of the vaccine makes
alternative, less expensive forms of treatment prefer-
able. This ﬁnding is consistent with other literature
in Kenya noting that the high cost of conventional
Western drugs often makes them inaccessible, thereby
promoting reliance on traditional remedies [33].
Pluralistic health-seeking practices, including tra-
ditional remedies, are widely used in other African
countries [34] ; however, in our study they appear to
compete with biomedical interventions, especially
when the higher cost of vaccine becomes a barrier.
The priority of prayer, on the other hand, was
complementary to vaccine interventions – an ad-
ditional, rather than alternative source of help. Other
studies suggest religious beliefs may be antagonistic to
vaccine intervention [35, 36]. A study in Benin found
that vaccination was rejected in some religious com-
munities because they believed that they ‘require only
prayer to protect and heal them in times of illness ’
[37]. The ﬁnding in Kenya, that reporting self-help
with prayer was signiﬁcantly associated with OCV
acceptance, suggests a possible role played by re-
ligious institutions in encouraging the use of bio-
medicine. Although religious sectarian diﬀerences
may inﬂuence the perceived beneﬁts of medical inter-
ventions, we found no diﬀerences in anticipated OCV
acceptance in members of the Legio Maria church,
which some studies suggest may promote faith healing
and reject biomedicine [38], and members of other
church groups.
Financial viability, based on reporting a regular
household income and a smaller household size, in-
ﬂuenced OCV acceptance. While this ﬁnding is
what would be expected for relatively high-priced
vaccines, it underscores the importance of keeping
costs reasonable. Furthermore, as the price of OCV
was increased, determinants that had inﬂuenced vac-
cine acceptance at a lower price, such as education,
were no longer relevant. The increasing price levels of
OCV were introduced to provide an indication of
priority and demand for the vaccine. Findings suggest
that regardless of priorities and commitment to ob-
tain an OCV, above a certain price it was simply
beyond the means of many. In this study, the high
price was the threshold. Hence, a full-cost recovery
model with Dukoral may not be considered in this
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setting. However, it may be considered for OCVs
that can be produced at a far lower cost, such as
Shanchol [39].
Analysis of OCV acceptance did not reveal signiﬁ-
cant site-speciﬁc determinants; socio-cultural factors
inﬂuencing OCV acceptance for urban and rural
residents were similar. However, enthusiasm for an
OCV was signiﬁcantly higher in urban than rural
respondents at the medium and high prices. This may
be explained by the presence of greater disposable
income and better education as has been observed
in another vaccine study [32] or by higher perceived
risk and vulnerability to the disease. In this study,
both hypotheses remain plausible, as the urban
respondents have better incomes and education than
their rural counterparts. They also may attach a
greater priority to receiving an OCV given the more
crowded and unsanitary conditions that they have to
contend with.
The main limitation of this study is the ability to
relate anticipated acceptance with actual acceptance
in the context of a vaccine campaign. Recognizing that
there is a diﬀerence between what people say and
what they actually do [40] anticipated acceptance
may not perfectly guide actual acceptance. Inasmuch
as this study provided a community assessment of
vaccine demand and ﬁndings on predictors of OCV
acceptance which support reasonable expectations
(e.g. secondary school education was a predictor for
OCV acceptance), further research addressing the
nature of the relationship between anticipated and
actual acceptance is needed. It also remains to be seen
whether the predictors of anticipated OCV acceptance
would remain signiﬁcant in the context of an actual
mass vaccination campaign.
Further research could include an assessment of
whether ﬁndings from this study may be generalized
across other settings. At some level we expect broad
similarities in factors inﬂuencing OCV acceptance;
however, particular priorities may be culture-speciﬁc.
It would be fruitful to develop a framework for vac-
cine acceptance by conducting more such studies in
diﬀerent settings to explain common features and
context-speciﬁc diﬀerences.
In conclusion, this study found high levels of
interest for an OCV in community residents in
Western Kenya, although vaccine cost was revealed as
a critical consideration. Socio-cultural factors played
an important role in anticipated OCV acceptance
and speciﬁc determinants were identiﬁed. This re-
search also provides an approach for the study of
socio-cultural determinants and barriers to vaccine
acceptance in other settings.
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